142 related articles for article (PubMed ID: 9988942)
1. [Incremental doses of diltiazem in patients with coronary artery disease in end-stage renal failure maintained on hemodialysis: which is the optimal dose?].
Cice G; Ferrara L; Tagliamonte E; Di Benedetto A; Iacono A
Cardiologia; 1998 Dec; 43(12):1337-43. PubMed ID: 9988942
[TBL] [Abstract][Full Text] [Related]
2. [Effectiveness and tolerability of bisoprolol vs. nifedipine in uremic patients with ischemic cardiopathy in dialysis treatment].
Cice G; Di Benedetto A; Tagliamonte E; Ferrara L; Sorice P; Iacono A
Cardiologia; 1997 Apr; 42(4):397-403. PubMed ID: 9244644
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release diltiazem reduces myocardial ischemic episodes in end-stage renal disease: a double-blind, randomized, crossover, placebo-controlled trial.
Cice G; Di Benedetto A; D'Andrea A; D'Isa S; Ferrara L; Russo PE; Iacono A; Calabrò R
J Am Soc Nephrol; 2003 Apr; 14(4):1006-11. PubMed ID: 12660335
[TBL] [Abstract][Full Text] [Related]
4. [Effectiveness of various combination therapies in patients with coronary heart disease].
Lehmann G; Reiniger G; Wolf H; Beyerle A; Rudolph W
Herz; 1990 Dec; 15(6):399-409. PubMed ID: 1980660
[TBL] [Abstract][Full Text] [Related]
5. Role of diltiazem in the treatment of silent myocardial ischemia.
Waters D; Juneau M; Baird M; Klinke P; Warnica W; Chin C; Théroux P
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S15-20. PubMed ID: 1725537
[TBL] [Abstract][Full Text] [Related]
6. [Comparative effect of anti-anginal drugs on myocardial ischemia in patient with effort angina: evaluation by ambulatory electrocardiographic monitoring].
Suzuki Y
Hokkaido Igaku Zasshi; 1991 Jul; 66(4):441-9. PubMed ID: 1680782
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of anti-ischemic effect of bepridil and diltiazem evaluated by exercise test in patients with coronary disease. A multicenter study. Groupe d'Investigateurs].
Sellier P; Quilliet L
Ann Cardiol Angeiol (Paris); 1997 Nov; 46(9):602-8. PubMed ID: 9538375
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the antispastic effect of Bi-Tildiem 120 mg and Tildiem 60mg].
Yvorra S; Desfossez L; Panagides D; De La Garoullaye A; Bory M
Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):372-7. PubMed ID: 8561443
[TBL] [Abstract][Full Text] [Related]
9. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of diltiazem in variant angina. Results of a double-blind crossover study in CCU by Holter monitoring. The possible occurrence of a withdrawal syndrome.
Pesola A; Lauro A; Gallo R; Madeo A; Cosentino G
G Ital Cardiol; 1987 Apr; 17(4):329-39. PubMed ID: 3653590
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of diltiazem in uremic hemodialyzed patients with isolated diastolic dysfunction and dialysis hypotensive crisis].
Cice G; Tagliamonte E; Ferrara L; Di Benedetto A; Sorice P; Iacono A
Cardiologia; 1999 Mar; 44(3):289-94. PubMed ID: 10327731
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, placebo-controlled trial of sustained-release diltiazem in patients with angina. Sustained-Release Diltiazem Study Group.
Weiss RJ; Hicks D; Bittar N; Bowers J; Shah A
Clin Ther; 1993; 15(6):1069-75. PubMed ID: 8111804
[TBL] [Abstract][Full Text] [Related]
13. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
Marazzi G; Wajngarten M; Vitale C; Patrizi R; Pelliccia F; Gebara O; Pierri H; Ramires JA; Volterrani M; Fini M; Rosano GM
Int J Cardiol; 2007 Aug; 120(1):79-84. PubMed ID: 17134770
[TBL] [Abstract][Full Text] [Related]
14. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
15. [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease].
Hopf R; Fleischer K; Forster A; Mohler C; Schulz PC; Kaltenbach M
Z Kardiol; 1989; 78 Suppl 5():69-76. PubMed ID: 2698566
[TBL] [Abstract][Full Text] [Related]
16. [Diltiazem in spontaneous angina: double-blind cross-over study with Holter monitoring].
Fazzini PF; Multino D; Zambaldi G
G Ital Cardiol; 1985 Nov; 15(11):1085-9. PubMed ID: 3830764
[TBL] [Abstract][Full Text] [Related]
17. [The calcium antagonists diltiazem and nifedipine: a comparison of their efficacy in single and long-term use in patients with stable stenocardia of effort].
Martsevich SIu; Kutishenko PP; Alimova EV; Slastnikova ID; Metelitsa VI
Ter Arkh; 1998; 70(8):21-5. PubMed ID: 9770738
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of a once-daily graded-release diltiazem formulation dosed at bedtime compared to placebo and to morning dosing in chronic stable angina pectoris.
Glasser SP; Gana TJ; Pascual LG; Albert KS
Am Heart J; 2005 Feb; 149(2):e1-9. PubMed ID: 15846251
[TBL] [Abstract][Full Text] [Related]
19. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow.
Fugit MD; Rubal BJ; Donovan DJ
J Invasive Cardiol; 2000 Feb; 12(2):80-5. PubMed ID: 10731269
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive assessment of left ventricular performance in patients with coronary artery disease after chronic diltiazem therapy.
Cinquegrana G; Spinelli L; Ferro G; Cristiano C; Spadafora M; Ferrara M
Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):27-9. PubMed ID: 2744903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
